AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis

NCT00769028 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Sclerosis

Interventions

DRUG: Hyperimmune caprine serum
DRUG: Albumin

Sponsor

Daval International Limited